Indexed metadata
Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network
C. Soussain, S. Choquet, M. Blonski, D. Leclercq, C. Houillier, K. Rezai, F. Bijou, R. Houot, E. Boyle, R. Gressin, E. Nicolas-Virelizier, M. Barrie, C. Moluçon-Chabrot, M.L. Lelez, A. Clavert, S. Coisy, S. Leruez, V. Touitou, N. Cassoux, M. Daniau, M. Ertault de la Bretonnière, A. El Yamani, H. Ghesquières, K. Hoang-Xuan
Source record
Source: Crossref
Published: Aug 1, 2019
DOI: 10.1016/j.ejca.2019.05.024
Open original source ↗Evidence graph
No public relationships recorded yet.
Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.